XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2025
Sep. 30, 2024
Current Assets:    
Cash and equivalents $ 667 $ 1,717
Restricted cash 80 139
Short-term investments 16 445
Trade receivables, net 3,029 3,033
Inventories:    
Materials 892 803
Work in process 487 443
Finished products 2,344 2,597
Inventories 3,723 3,843
Prepaid expenses and other 1,150 1,292
Total Current Assets 8,666 10,468
Property, Plant and Equipment 14,409 14,378
Less allowances for depreciation and amortization 7,763 7,557
Property, Plant and Equipment, Net 6,646 6,821
Goodwill 26,444 26,465
Developed Technology, Net 7,171 7,733
Customer Relationships, Net 2,434 2,635
Other Intangibles, Net 530 549
Other Assets 2,577 2,615
Total Assets 54,467 57,286
Current Liabilities:    
Current debt obligations 1,604 2,170
Payables, accrued expenses and other current liabilities 6,087 6,786
Total Current Liabilities 7,691 8,956
Long-Term Debt 17,666 17,940
Long-Term Employee Benefit Obligations 871 942
Deferred Income Taxes and Other Liabilities 2,998 3,558
Commitments and Contingencies (See Note 5)
Shareholders’ Equity    
Common stock — $1 par value; authorized — 640,000,000 shares; issued — 370,594,401 shares in March 31, 2025 and September 30, 2024 371 371
Capital in excess of par value 19,971 19,893
Retained earnings 16,150 16,139
Deferred compensation 26 25
Treasury stock (9,561) (8,807)
Accumulated other comprehensive loss (1,716) (1,732)
Total Shareholders’ Equity 25,241 25,890
Total Liabilities and Shareholders’ Equity $ 54,467 $ 57,286